Awarded the 2019 Nobel Prize for discovering HIF‑1, the key regulator of cellular oxygen response, Dr. Semenza revealed how HIF-driven pathways fuel chemoresistance by enhancing cancer stem cell survival. Blocking HIF signaling in preclinical models reversed resistance in approximately 60+% of refractory tumors, setting a new precedent in targeted metabolic intervention.